Literature DB >> 19214050

The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder.

Baojin Zhu1, Zhongyun Zhao, Wenyu Ye, Martin D Marciniak, Ralph Swindle.   

Abstract

Patients with generalized anxiety disorder (GAD) often have comorbid medical and psychiatric disorders and may incur higher costs. In this study, a total of 36,435 GAD patients aged 18 to 64 were identified from a claims database. Patient's total health care and component costs were compared between GAD patients with and without comorbid depression and pain using general linear models. The average total annual cost for all the GAD patients in the study was $7451. Compared with patients with GAD-only, the estimated total cost was $762 higher for GAD with depression (p < 0.001), $2989 higher for GAD with pain (p < 0.001), and $6073 higher for GAD with both depression and pain (p < 0.001). Comorbid depression and pain had significant impact on costs, especially those with pain or with both depression and pain. This suggests that an optimal strategy for GAD should take into account comorbid pain and depression.

Entities:  

Mesh:

Year:  2009        PMID: 19214050     DOI: 10.1097/NMD.0b013e3181963486

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  7 in total

1.  Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis.

Authors:  Martha Sajatovic; Daisy Ng-Mak; Caitlyn T Solem; Fang-Ju Lin; Krithika Rajagopalan; Antony Loebel
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-13

2.  Duloxetine in the treatment of generalized anxiety disorder.

Authors:  Alan Wright; Chad Vandenberg
Journal:  Int J Gen Med       Date:  2009-12-29

Review 3.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

4.  Anxiety, depression and methods of stress coping in patients with nicotine dependence syndrome.

Authors:  Tadeusz Pietras; Andrzej Witusik; Michał Panek; Janusz Szemraj; Paweł Górski
Journal:  Med Sci Monit       Date:  2011-05

5.  The incremental burden of pain in patients with depression: results of a Japanese survey.

Authors:  Jeffrey Vietri; Tempei Otsubo; William Montgomery; Toshinaga Tsuji; Eiji Harada
Journal:  BMC Psychiatry       Date:  2015-05-07       Impact factor: 3.630

6.  Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey.

Authors:  Jeffrey Vietri; Tempei Otsubo; William Montgomery; Toshinaga Tsuji; Eiji Harada
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-13       Impact factor: 2.570

7.  Quality of life and use of health care resources among patients with chronic depression.

Authors:  Renata Villoro; María Merino; Alvaro Hidalgo-Vega
Journal:  Patient Relat Outcome Meas       Date:  2016-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.